"}
SARS-CoV-IN-1 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-1 shows anti-Coronavirus activity with an EC 50 of 4.9 μM in Vero cells. SARS-CoV-IN-1 inhibits the 3D7 and W2 strains of P. falciparum with IC 50 s of 15.4 and 133.2 nM; and IC 90 s of 25.7 and 459.1 nM; respectively. Antimalarial and antiviral activities
In Vitro
SARS-CoV-IN-1 (Compound 2) inhibits in vitro growth of Plasmodium falciparum far better than Chloroquine (CQ). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
IC50& Target:Plasmodium
| CAS | 888958-25-6 |
|---|---|
| Concentration | 10mM in DMSO |
| Specifications & Purity | 10mM in DMSO |
| Storage | Store at -80°C |
| Shipped In | Dry ice packs + Cold packs |
| Product Description | SARS-CoV-IN-1 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-1 shows anti-Coronavirus activity with an EC 50 of 4.9 μM in Vero cells. SARS-CoV-IN-1 inhibits the 3D7 and W2 strains of P. falciparum with IC 50 s of 15.4 and 133.2 nM; and IC 90 s of 25.7 and 459.1 nM; respectively. Antimalarial and antiviral activities In Vitro SARS-CoV-IN-1 (Compound 2) inhibits in vitro growth of Plasmodium falciparum far better than Chloroquine (CQ). MCE has not independently confirmed the accuracy of these methods. They are for reference only. IC50& Target:Plasmodium |